NeuroTrauma Sciences

NeuroTrauma Sciences (NTS) is a biopharmaceutical company advancing its mission to develop therapies that address the full complexities of acquired brain injuries including traumatic brain injury (TBI), stroke, and other neurologic conditions. Acquired brain injuries remain areas of high unmet need with limited therapeutic options to alleviate the cognitive, functional, and neurobehavioral effects for the millions of patients worldwide. By following the science and leveraging insights into the biology of acquired brain injury, NTS is advancing a pipeline of candidates targeting TBI and stroke.